|
1WYL
Solution structure of the CH domain of human NEDD9 interacting protein with calponin homology and LIM domains
Deposited 2005-02-15
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
510–612(103 aa)
Fragment:CH domain
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;296 K;Ionic strength (raw mmCIF value) 120mM;Pressure ambient
NMR sample composition
1.22mM CH domain U-15N, 13C; 20mM d-Tris-HCl; 100mM NaCl; 1mM d-DTT; 0.02% NaN3; 10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
2CO8
Solution structures of the LIM domain of human NEDD9 interacting protein with calponin homology and LIM domains
Deposited 2005-05-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
687–755(69 aa)
Fragment:LIM domain
|
Not recorded
|
ZN ZINC ION × 2
|
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 120mM;Pressure ambient
NMR sample composition
1mM LIM domain U-15N,13C; 20mM d-Tris HCl; 100mM NaCl; 1mM d-DTT; 0.02% NaN3; 0.01mM ZnCl2; 10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
2DK9
Solution structure of Calponin Homology domain of Human MICAL-1
Deposited 2006-04-07
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
506–614(109 aa)
Fragment:Calponin Homology domain
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.5;293 K;Ionic strength (raw mmCIF value) 50mM phosphate buffer, 50mM NaCl;Pressure 1
NMR sample composition
1.5mM MICAL_1 CH U-15N,13C; 50mM phosphate buffer, 50mM NaCl; 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
1.5mM MICAL_1 CH U-15N; 50mM phosphate buffer, 50mM NaCl; 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
1.5mM MICAL_1 CH U-15N,13C; 50mM phosphate buffer, 50mM NaCl; 100% D2O | 100% D2O
NMR sample composition
1.5mM MICAL_1 CH U-15N; 50mM phosphate buffer, 50mM NaCl; 17 mg/mL Pf1 filamentous phage; 90% H2O, 10% D2O | 17 mg/mL Pf1 filamentous phage; 90% H2O, 10% D2O
|
Resolution not provided
|
|
5LE0
MICAL1 Cterminal domain
Deposited 2016-06-29
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
918–1067(150 aa)
Fragment:UNP residues 918-1067
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;290 K;EG
|
Resolution 3.30 Å
R-free 0.306
|
|
6KU0
Crystal structure of MyoVa-GTD in complex with MICAL1-GTBM
Deposited 2019-08-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
799–822(24 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;1% w/v Tryptone, 0.05M HEPES sodium pH 7.0, 20% w/v Polyethylene glycol 3350
|
Resolution 1.60 Å
R-free 0.199
|
|
6KU0
Crystal structure of MyoVa-GTD in complex with MICAL1-GTBM
Deposited 2019-08-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
799–822(24 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;1% w/v Tryptone, 0.05M HEPES sodium pH 7.0, 20% w/v Polyethylene glycol 3350
|
Resolution 1.60 Å
R-free 0.199
|
|
8HLO
Crystal structure of ASAP1-SH3 and MICAL1-PRM complex
Deposited 2022-11-30
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
828–836(9 aa)
|
Not recorded
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.4;289.15 K;0.1M HEPES, pH 7.5, 1.4M Sodium citrate tribasic dihydrate
|
Resolution 1.17 Å
R-free 0.142
|
|
8Y6K
Cryo-EM structure of full-length MICAL1 in the autoinhibited state
Deposited 2024-02-02
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–1067(1067 aa)
|
Not recorded
|
ZN ZINC ION × 2
FAD FLAVIN-ADENINE DINUCLEOTIDE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;50 mM Tris, pH 7.5, 100 mM NaCl, 2 mM MgCl2, 2 mM DTT.
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.94 Å
|
|
9EWY
CryoEM structure of human MICAL1
Deposited 2024-04-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–1067(1067 aa)
|
Not recorded
|
FAD FLAVIN-ADENINE DINUCLEOTIDE × 1
ZN ZINC ION × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.10 Å
|
|
9G0C
Structure of human Mical1 bMERB_V978A_V985A domain:Rab10 complex.
Deposited 2024-07-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
918–1067(150 aa)
|
Mutation:V978A, V985A
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;0.17 M Sodium acetate, 0.085 M Tris-HCl pH 8.5, 25.5% (w/v) PEG 4000 and 15% (v/v) glycerol
|
Resolution 1.80 Å
R-free 0.231
|
|
9G0D
Structure of human Mical1 bMERB_V978A domain:Rab10 complex.
Deposited 2024-07-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
918–1067(150 aa)
|
Mutation:V978A
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;0.1 M Imidazole pH 8.0, 5% (w/v) PEG 3000 and 30% (v/v) PEG 200
|
Resolution 2.05 Å
R-free 0.249
|